You are here

  • Home
  • Archive
  • Volume 57, Issue 14
  • PFD-SENTINEL: Development of a screening tool for pelvic floor dysfunction in female athletes through an international Delphi consensus

Responses

Article menu
Consensus statement
PFD-SENTINEL: Development of a screening tool for pelvic floor dysfunction in female athletes through an international Delphi consensus
Free
Compose a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on: 13 September 2023
    Response to: Did the authors consider the ICIQ-FLUTs (Neil Heron)

    On behalf of all authors, I would like to express our gratitude for the attention given to our work and for providing a thorough response.
    We agree that the ICIQ-FLUTs tool has been identified as a reliable instrument for evaluating lower urinary tract symptoms (LUTS); however, our objective extended beyond solely assessing LUTS. We aimed to incorporate a comprehensive range of symptoms, encompassing pelvic organ prolapse, anal incontinence, and pelvic pain.
    Additional and complete information regarding the rationale behind this decision can be found in the Supplementary file 3.
    Then, we sought the expertise of panellists in rating each symptom for potential inclusion in the tool.
    I am open to further discuss. Thank you again.
    Regards,
    Silvia

    Conflict of Interest:
    None declared.
  • Published on: 20 July 2023
    Did the authors consider the ICIQ-FLUTs
    • Neil Heron, Sport medicine clinician / researcher Queen’s University Belfast

    Dear Giagio et Al,

    I read with interest your PFD -SENTINEL paper and thank you for putting together this consensus process.

    As practising sport medicine physicians, we have an interest in lower urinary tract symptoms (LUTs), including incontinence, within our athletic population, both males and females. LUTs, as part of pelvic floor dysfunction, are reportedly common in the general population (2) and vary with the age of the population surveyed – with one recent survey estimating a prevalence of over 70% in those over the age of 70 years olds (3). LUTs is a group of various symptoms related to urination and can include leaking urine, sudden and frequent urges to pass urine, having a weak urine stream or a feeling that you have not completely emptied your bladder. LUTS, and particularly Urinary Incontinence (UI), are considered to be a female health problem that is inevitable and the result of life and health events such as pregnancy, childbirth, and menopause (Casey, E. & Temme, K. 2017). The issue of LUTs is less well understood in male athletes although it has been reported to be present in approximately 15% of athletes surveyed in one study (1). The acceptance of these symptoms, particularly within female athletes, often leads to under reporting or poor engagement with health care practitioners to assess and manage the condition (Anderson & Anderson 2011, Almousa & Bandin Van Loon, 2019, Rodríguez-López, E.S., et al. 2020). The impact of LUT...

    Show More
    Conflict of Interest:
    None declared.